Detection of
breast cancer
circulating tumor DNA (ctDNA)
early-stage cancer
liquid biopsy
molecular profiling
Journal
Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588
Informations de publication
Date de publication:
07 Aug 2019
07 Aug 2019
Historique:
received:
18
07
2019
revised:
02
08
2019
accepted:
06
08
2019
entrez:
10
8
2019
pubmed:
10
8
2019
medline:
10
8
2019
Statut:
epublish
Résumé
Circulating tumor DNA (ctDNA) has emerged as a non-invasive "liquid biopsy" for early breast cancer diagnosis. We evaluated the suitability of ctDNA analysis in the diagnosis of early breast cancer after mammography findings, comparing
Identifiants
pubmed: 31394872
pii: jcm8081183
doi: 10.3390/jcm8081183
pmc: PMC6723048
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Instituto de Salud Carlos III
ID : Miguel Servet Type II, CPI13/00003
Organisme : Consejería de Salud. Junta de Andalucía
ID : Nicolas Monardes, C-0030-2018
Déclaration de conflit d'intérêts
The authors declare no conflict of interest.
Références
Science. 2004 Apr 23;304(5670):554
pubmed: 15016963
J Clin Oncol. 2007 Jan 1;25(1):118-45
pubmed: 17159189
Cancer Res. 2007 Oct 1;67(19):9364-70
pubmed: 17909045
Nat Med. 2008 Sep;14(9):985-90
pubmed: 18670422
Proc Natl Acad Sci U S A. 2011 Jun 7;108(23):9530-5
pubmed: 21586637
N Engl J Med. 2012 Mar 8;366(10):883-892
pubmed: 22397650
Nature. 2012 Oct 4;490(7418):61-70
pubmed: 23000897
N Engl J Med. 2013 Mar 28;368(13):1199-209
pubmed: 23484797
N Engl J Med. 2013 Jul 4;369(1):93-4
pubmed: 23822788
J Clin Oncol. 2014 Feb 20;32(6):579-86
pubmed: 24449238
Clin Cancer Res. 2014 May 15;20(10):2643-2650
pubmed: 24504125
Sci Transl Med. 2014 Feb 19;6(224):224ra24
pubmed: 24553385
Int J Cancer. 2015 May 1;136(9):2158-65
pubmed: 25307450
N Engl J Med. 2014 Dec 25;371(26):2477-87
pubmed: 25426838
BMC Med. 2014 Dec 16;12:240
pubmed: 25511686
Gut. 2016 Apr;65(4):625-34
pubmed: 25654990
Breast Cancer Res Treat. 2015 Apr;150(2):299-307
pubmed: 25736040
Ann Oncol. 2015 Aug;26(8):1715-22
pubmed: 25851626
Sci Transl Med. 2015 Aug 26;7(302):302ra133
pubmed: 26311728
Nat Biotechnol. 2016 Feb;34(2):155-63
pubmed: 26619011
Clin Cancer Res. 2016 Nov 15;22(22):5497-5505
pubmed: 27185373
Adv Exp Med Biol. 2016;924:187-189
pubmed: 27753042
Cold Spring Harb Perspect Med. 2017 Jan 3;7(1):null
pubmed: 27815305
Clin Chem. 2017 Mar;63(3):691-699
pubmed: 28073896
Expert Rev Mol Diagn. 2017 Mar;17(3):209-215
pubmed: 28129709
Cancer Biomark. 2017;19(1):85-92
pubmed: 28269754
Int J Cancer. 2017 Sep 1;141(5):977-985
pubmed: 28543104
N Engl J Med. 2017 Aug 10;377(6):513-522
pubmed: 28792880
Sci Transl Med. 2017 Aug 16;9(403):null
pubmed: 28814544
Eur J Cancer. 2018 Jan;88:1-9
pubmed: 29175734
Science. 2018 Feb 23;359(6378):926-930
pubmed: 29348365
CA Cancer J Clin. 2018 Jul;68(4):297-316
pubmed: 29846940
Curr Oncol. 2018 Jun;25(Suppl 1):S115-S124
pubmed: 29910654
BMC Cancer. 2018 Jul 9;18(1):726
pubmed: 29986670
JAMA Oncol. 2018 Dec 1;4(12):1700-1706
pubmed: 30054636
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593
Clin Genet. 2019 Jun;95(6):643-660
pubmed: 30671931
Mol Oncol. 2019 May;13(5):1033-1046
pubmed: 30672098
Cancer Treat Rev. 2019 Feb;73:73-83
pubmed: 30682661
NPJ Precis Oncol. 2019 Jan 28;3:3
pubmed: 30701196
Ann Oncol. 2019 Mar 12;:null
pubmed: 30860573